Table 1 Characterization of patients with autoimmune gastritis in this study.

A1

1465​

6.6​

11.0

0.6​

Negative​

Corpus dominant

advanced atrophy​

A2

1806​

7.7​

10.0​

0.8​

Negative​

A3

4342​

3.0

6.4​

0.5​

N/A​*

Corpus dominant

advanced atrophy​

A4

3547​

8.5​

12.2​

0.7​

Negative​

Corpus dominant

advanced atrophy​

A5

1929​

2.5​

6.1​

0.4​

Negative​

Corpus dominant

advanced atrophy​

A6

1651​

N/A​

N/A​

N/A​

N/A​

Corpus dominant

advanced atrophy​

A7

5682

24.5

38.4

0.6

Negative​

Corpus dominant

advanced atrophy​

A8

6655​

4.1​

8.6​

0.5​

Negative​

Corpus dominant

advanced atrophy​

A9

2742​

11.0​

12.3​

0.9​

Negative​

Corpus dominant

advanced atrophy​

A10

6223​

14.6​

17.6​

0.8​

Negative​

Corpus dominant

advanced atrophy​

A11

2311​

1.4​

7.0

0.2​

Negative​

Corpus dominant

advanced atrophy​

A12

2342​

2.3​

7.4​

0.3​

Negative​

Corpus dominant

advanced atrophy​

A13

3843​

29.0

16.2​

1.8​

Negative​

Corpus dominant

advanced atrophy​

A14

879​

10.1​

6.5​

1.6​

Negative​

A15

3012​

10.7​

19.4​

0.6​

Negative​

Corpus dominant

advanced atrophy​

A16

N/A​

5.5

16.8

0.3

Negative​

Corpus dominant

advanced atrophy​

A17

849

136.7

24.1

5.7

Negative​

Corpus dominant

advanced atrophy​

A18

522

1.1

5.9

0.2

N/A​

Corpus dominant

advanced atrophy​

A19

287

N/A​

N/A​

N/A​

Negative​

Corpus dominant

advanced atrophy​

A20

N/A​

3.0

9.3

0.3

Negative